Brief Title: Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

PRIMARY OUTCOMES

Primary Outcome 1 - Measure: Rate of adherence to BCG therapy at 3 months after study initiation

Primary Outcome 1 - Timeframe: 3 months after study initiation

CONDITION

• Bladder Cancer

ELIGIBILITY

Inclusion Criteria:
Inclusion criteria for patients in Cohort 1
* Age 18 years or older;

- * completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders

- * Age 18 years or older;

- * experience with the delivery of BCG delivery for more than 2 years
Cohort 2 inclusion criteria
* Age 18 years or older;

- * diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy
Exclusion Criteria:
Cohort 1 exclusion criteria
• inability to provide informed consent
Cohort 2 exclusion criteria
* inability to provide informed consent

- * inability to undergo catheterization (i.e. - history of urethral stricture)

- * inability to receive BCG therapy (i.e. - previous reaction with BCG)

- * no access to mobile phone

- * inability to respond to written conversations in English

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

OFFICIAL INFORMATION

Name: N/A

Role: N/A

Affiliation: N/A

Overall Contact

Name: Daniel Lee, PI, MD

Phone: 215-615-3780

Email: [email protected]

LOCATION